GOVX - GeoVax Labs, Inc.

0.9701
0.018   1.855%

Share volume: 461,473
Last Updated: 04-08-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.05%

PREVIOUS CLOSE
CHG
CHG%
$0.95
0.02
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
30%
Profitability 0%
Dept financing 50%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.89%
1 Month
-42.60%
3 Months
-56.50%
6 Months
-56.50%
1 Year
-50.25%
2 Year
38.98%
Key data
Stock price
$0.97
P/E Ratio 
0.00
DAY RANGE
$0.97 - $1.08
EPS 
-$6.96
52 WEEK RANGE
$0.88 - $11.18
52 WEEK CHANGE
-$48.40
MARKET CAP 
23.307 M
YIELD 
N/A
SHARES OUTSTANDING 
5.264 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
7.35
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$376,768
AVERAGE 30 VOLUME 
$557,380
Company detail
CEO: David A. Dodd
Region: US
Website: geovax.com
Employees: 10
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

GeoVax Labs, Inc. develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV) and malaria.

Recent news
loading